FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Speiser

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Genes, p53

Co-author Network

Publications

TOP 3
Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Nicole Concin; Gudrun Hager; Georg Heinze; Maria Kohl; Sven Mahner; Eva Obermayr; Robert Zeillinger
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
Stefanie Aust; Christoph Grimm; Peter Horak; Reinhard Horvat; Dietmar Pils; Sophie Pils; Alexander Reinthaller; Bernd Schmid; Paul Speiser; Dan Cacsire Castillo-Tong; Stephan Polterauer
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Eva Obermayr; Dietmar Pils; Jalid Sehouli; Paul Speiser; Toon Van Gorp; Ignace Vergote; Ioana Braicu; Dan Cacsire Castillo-Tong; Sven Mahner; Robert Zeillinger
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Speiser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Nicole Concin; Gudrun Hager; Georg Heinze; Maria Kohl; Sven Mahner; Eva Obermayr; Robert Zeillinger
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
BMC cancer 2013;13():178.
2013: Stefanie Aust; Christoph Grimm; Peter Horak; Reinhard Horvat; Dietmar Pils; Sophie Pils; Alexander Reinthaller; Bernd Schmid; Paul Speiser; Dan Cacsire Castillo-Tong; Stephan Polterauer
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
BMC cancer 2013;13():115.
2013: Eva Obermayr; Dietmar Pils; Jalid Sehouli; Paul Speiser; Toon Van Gorp; Ignace Vergote; Ioana Braicu; Dan Cacsire Castillo-Tong; Sven Mahner; Robert Zeillinger
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.
Gynecologic oncology 2013;128(1):15-21.
2012: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Isabelle Cadron; Gudrun Hager; Georg Heinze; Gerda Hofstetter; Maria Kohl; Sven Mahner; Robert Zeillinger
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Cancer science 2012;103(7):1334-41.
2012: Stefanie Aust; Anna Bachmayr-Heyda; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert; Reinhard Horvat; Sven Mahner; Petra Pateisky; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Robert Zeillinger; Dietmar Pils
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
Molecular cancer 2012;11():69.
2010: Veronika Auner; Jalid Sehouli; Gülten Oskay-Oezcelik; Reinhard Horvat; Paul Speiser; Robert Zeillinger
ABC transporter gene expression in benign and malignant ovarian tissue.
Gynecologic oncology 2010;117(2):198-201.
2008: Lukas Hefler; Stephan Polterauer; Gustav Nowotny; Clemens Tempfer; Petra Kohlberger; Gerhard Sliutz; Paul Speiser; Elmar A Joura; Alexander Reinthaller
Necessity of colposcopy and biopsy prior to large loop excision of the transformation zone (LLETZ).
Anticancer research 2008;28(1B):519-21.
2007: Stephan Polterauer; Christoph Grimm; Clemens Tempfer; Gerhard Sliutz; Paul Speiser; Alexander Reinthaller; Lukas A Hefler
C-reactive protein is a prognostic parameter in patients with cervical cancer.
Gynecologic oncology 2007;107(1):114-7.
2007: Barbara Tringler; Christoph Grimm; Grazyna Dudek; Robert Zeillinger; Clemens Tempfer; Paul Speiser; Elmar A Joura; Alexander Reinthaller; Lukas A Hefler
p16INK4a expression in invasive vulvar squamous cell carcinoma.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(3):279-83.
2007: Petra Kohlberger; Gustav Nowotny; Paul Speiser; Elmar A Joura; Gerhard Sliutz; Lukas Hefler; Alexander Reinthaller
Surgical treatment of endometrial cancer: does closure or non-closure of the vagina affect the local recurrence rate?
Anticancer research 2007;27(3B):1589-91.
2006: Lukas A Hefler; Christoph Grimm; Paul Speiser; Gerhard Sliutz; Alexander Reinthaller
The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial.
European journal of obstetrics, gynecology, and reproductive biology 2006;125(2):251-4.
2006: Lucia Six; Christoph Grimm; Sepp Leodolter; Clemens Tempfer; Robert Zeillinger; Gerhard Sliutz; Paul Speiser; Alexander Reinthaller; Lukas A Hefler
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
Gynecologic oncology 2006;100(3):506-10.
2005: Christoph Grimm; Lucia Six; Caroline Tomovski; Paul Speiser; Elmar A Joura; Robert Zeillinger; Gerhard Sliutz; Alexander Reinthaller; Lukas A Hefler
A common interleukin-6 promoter polymorphism in patients with vulvar cancer.
Journal of the Society for Gynecologic Investigation 2005;12(8):617-20.
2005: Barbara Tringler; Christoph Grimm; Gerhard Sliutz; Sepp Leodolter; Paul Speiser; Alexander Reinthaller; Lukas A Hefler
Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Gynecologic oncology 2005;99(1):80-3.
2005: Gudrun Hager; Dan Cacsire-Castillo Tong; Ingrid Schiebel; Günther A Rezniczek; Rafal Watrowski; Paul Speiser; Robert Zeillinger
The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection.
Gynecologic oncology 2005;98(2):211-6.
2005: Lukas A Hefler; Gerhard Sliutz; Sepp Leodolter; Paul Speiser; Elmar A Joura; Alexander Reinthaller; Petra Kohlberger
Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
Gynecologic oncology 2005;97(3):904-7.
2005: Martina Baur; E Schernhammer; Margit Gneist; Paul Sevelda; Paul Speiser; Marcus Hudec; Christian Dittrich
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer.
British journal of cancer 2005;92(6):1019-25.
2005: J Jun Bouda; Ludmila Boudova; O Hes; M Havir; Clemens Tempfer; Petra Kohlberger; T Svoboda; Zdenek Rokyta; Paul Speiser
CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Anticancer research 2005;25(1B):617-22.
2003: Bernd Schmid; Magarethe Rudas; Gerhild Fabjani; Paul Speiser; Klaus Kaserer; Sepp Leodolter; Robert Zeillinger
Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
Oncology reports 2003;10(6):1981-5.
2003: Christian Dittrich; Paul Sevelda; H Salzer; Andreas Obermair; Paul Speiser; Gerhard Breitenecker; M Schemper; Alexandra Kaider
Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1129-40.
2003: Nicole Concin; Lukas Hefler; Jeroen van Bavel; Elisabeth Mueller-Holzner; Alain G Zeimet; Guenter Daxenbichler; Paul Speiser; Neville F Hacker; Christian Marth
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases.
Gynecologic oncology 2003;89(1):9-15.
2002: Gerhild Fabjani; Dan Cacsire Castillo-Tong; Klaus Czerwenka; Eva Schuster; Paul Speiser; Sepp Leodolter; Robert Zeillinger
Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.
Breast cancer research and treatment 2002;72(2):131-7.
2002: Lukas A Hefler; Nicole Concin; David Mincham; Jane Thompson; Nikkie B Swarte; Marion A van Eijkeren; Daisy M D S Sie-Go; Ian Hammond; Anthony J McCartney; Clemens B Tempfer; Paul Speiser
The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.
Cancer 2002;94(1):125-30.
1999: Dan Cacsire Castillo-Tong; Christian Schneeberger; Klaus Czerwenka; Rita K Schmutzler; Paul Speiser; Elisabeth Kucera; Nicole Concin; Ernst Kubista; Sepp Leodolter; Robert Zeillinger
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1497-502.
1999: Elisabeth Kucera; Paul Speiser; Michael Gnant; Laszlo Szabo; Hellmut Samonigg; Hubert Hausmaninger; Martina Mittlböck; Michael Fridrik; Michael Seifert; Ernst Kubista; A Reiner; R Zeillinger; Raimund Jakesz
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1999;35(3):398-405.
1998: Andreas Obermair; Paul Speiser; M Thoma; Alexandra Kaider; H Salzer; Christian Dittrich; Paul Sevelda
Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin.
International journal of oncology 1998;13(5):1023-30.
1998: Clemens Tempfer; Gerhard Sliutz; Gabriele Haeusler; Paul Speiser; Alexander Reinthaller; Gerhard Breitenecker; N Vavra; Christian Kainz
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
British journal of cancer 1998;78(8):1091-4.
1998: Andreas Obermair; Paul Speiser; Klaus Reisenberger; R Ullrich; Klaus Czerwenka; Alexandra Kaider; Robert Zeillinger; M Miksche
Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients.
Cancer letters 1998;130(1-2):69-76.
1998: Andreas Obermair; C Wanner; S Bilgi; Paul Speiser; Klaus Reisenberger; Alexandra Kaider; Christian Kainz; Sepp Leodolter; Gerhard Breitenecker; Gerald Gitsch
The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
Cancer 1998;82(4):689-96.
1997: Rita K Schmutzler; Erhard Bierhoff; T Werkhausen; Rolf Fimmers; Paul Speiser; Ernst Kubista; Dieter Krebs; Robert Zeillinger; Otmar D Wiestler; Andreas von Deimling
Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.
International journal of cancer. Journal international du cancer 1997;74(3):322-5.
1997: Paul Speiser; C Wanner; Clemens Tempfer; M Mittelböck; Engelbert Hanzal; Dagmar Bancher-Todesca; Gerald Gitsch; Alexander Reinthaller; Christian Kainz
CD44 is an independent prognostic factor in early-stage cervical cancer.
International journal of cancer. Journal international du cancer 1997;74(2):185-8.
1997: G Knappitsch; K Gruböck; H Salzer; Alexandra Kaider; Christine Kurz; N Vavra; Paul Speiser; Paul Sevelda
[Survival prognosis in ovarian carcinoma Figo stages III and IV: 1980-1985 versus 1986-1993. A comparison of 2 treatment periods].
Gynäkologisch-geburtshilfliche Rundschau 1997;37(4):221-6.
1997: Paul Speiser; Klaus Mayerhofer; Elisabeth Kucera; G Roch; M Mittelböck; Gerald Gitsch; Robert Zeillinger
pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters.
Anticancer research 1997;17(1B):679-83.
1997: J Fischer-Colbrie; Armin Witt; Harald Heinzl; Paul Speiser; Klaus Czerwenka; Paul Sevelda; Robert Zeillinger
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
Anticancer research 1997;17(1B):613-9.
1997: Klaus Mayerhofer; Elisabeth Kucera; Harald Zeisler; Paul Speiser; Alexander Reinthaller; Paul Sevelda
Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
Gynecologic oncology 1997;64(1):109-13.
1997: Gerhard Sliutz; W Schmidt; Clemens Tempfer; Paul Speiser; Gerald Gitsch; S Eder; Christian Schneeberger; Christian Kainz; Robert Zeillinger
Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis.
Gynecologic oncology 1997;64(1):93-8.
1996: Rita K Schmutzler; Rolf Fimmers; Erhard Bierhoff; B Lohmar; A Homann; Paul Speiser; Ernst Kubista; K Jaeger; Dieter Krebs; Robert Zeillinger; Otmar D Wiestler; Andreas von Deimling
Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer.
International journal of cancer. Journal international du cancer 1996;69(4):307-11.
1996: Paul Speiser; Elisabeth Gharehbaghi-Schnell; S Eder; A Haid; J Kovarík; R Nenutil; G Sauter; Christian Schneeberger; Borivoj Vojtesek; Christoph Wiltschke; Robert Zeillinger
A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
British journal of cancer 1996;74(2):269-73.
1996: Christian Schneeberger; S Eder; Paul Speiser; Robert Zeillinger
Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.
Anticancer research 1996;16(2):849-52.
1996: Klaus Mayerhofer; J Stolzlechner; S Yildiz; K Haider; Harald Heinzl; Raimund Jakesz; Martin Pecherstorfer; H Rosen; Paul Sevelda; Robert Zeillinger; Paul Speiser
[Plasminogen activator inhibitor 1 and prognosis in breast carcinoma].
Geburtshilfe und Frauenheilkunde 1996;56(1):23-7.
1996: Paul Speiser; Elisabeth Gharehbaghi-Schnell; Christian Schneeberger; S Eder; Robert Zeillinger
Microdissection as a means to verify allelic imbalance in tumour biology samples.
Anticancer research 1996;16(1):461-4.
1996: Robert Zeillinger; S Eder; Christian Schneeberger; R Ullrich; Paul Speiser; Hemma Swoboda
Cathepsin D and PAI-1 expression in human head and neck cancer.
Anticancer research 1996;16(1):449-53.
1995: Paul Speiser; C Wanner; G Breitenecker; P Kohlberger; C Kainz
CD-44 is not involved in the metastatic spread of ovarian cancer in vivo.
Anticancer research 1995;15(6B):2767-9.
1995: Christoph Wiltschke; michael krainer; Alexandra C Budinsky; A Berger; C Müller; Robert Zeillinger; Paul Speiser; Ernst Kubista; M Eibl; Christoph C Zielinski
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
British journal of cancer 1995;71(6):1292-6.
1995: Christian Schneeberger; Paul Speiser; fritz kury; Robert Zeillinger
Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain.
PCR methods and applications 1995;4(4):234-8.
1994: Paul Speiser; J Stolzlechner; K Haider; Harald Heinzl; Raimund Jakesz; Martin Pecherstorfer; H Rosen; Paul Sevelda; R Zeilliger
pS2 protein status fails to be an independent prognostic factor in an average breast cancer population.
Anticancer research 1994;14(5B):2125-30.
1993: Robert Zeillinger; Christian Schneeberger; Paul Speiser; fritz kury
Rapid quantitative analysis of differential PCR products by high-performance liquid chromatography.
BioTechniques 1993;15(1):89-95.
1993: Robert Zeillinger; fritz kury; Paul Speiser; Gerhard Sliutz; Klaus Czerwenka; Ernst Kubista
EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
Clinical biochemistry 1993;26(3):221-7.
1993: Robert Zeillinger; Christian Schneeberger; Paul Speiser; fritz kury
A simple method for isolation of DNA from blood clots suited for use in PCR.
BioTechniques 1993;14(2):202-3.
1993: Regine Ahner; Paul Speiser; K Swoboda; E Küffer; Christine Kurz; Paul Sevelda; Peter Husslein
[Hyperlipidemia-induced pancreatitis in pregnancy. Successful long-term treatment by extracorporeal elimination of triglyceride-rich lipoproteins].
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():337.
1993: E Küffer; B Fazeny; Paul Speiser; Christine Kurz; N Vavra; Paul Sevelda; Christian Dittrich
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study].
Gynäkologisch-geburtshilfliche Rundschau 1993;33 Suppl 1():296-8.
1992: Christian Schneeberger; fritz kury; J Larsen; Paul Speiser; Robert Zeillinger
A simple method for extraction of DNA from Guthrie cards.
PCR methods and applications 1992;2(2):177-9.
1992: Paul Speiser; Gerhard Sliutz; Robert Zeillinger; Klaus Czerwenka; Raimund Jakesz; Wolfgang Knogler; fritz kury; A Reiner; P Sevelda; Christian Schneeberger
[Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
Geburtshilfe und Frauenheilkunde 1992;52(6):355-9.
1992: Robert Zeillinger; Hemma Swoboda; E Machacek; D Nekahm; Gerhard Sliutz; Wolfgang Knogler; Paul Speiser; E Swoboda; Ernst Kubista
Expression of cathepsin D in head and neck cancer.
European journal of cancer (Oxford, England : 1990) 1992;28A(8-9):1413-5.
1992: Mahmood Manavi; Klaus Czerwenka; Robert Zeillinger; Paul Speiser; F Kury; U Steinhart; M Peschke; Ernst Kubista; E Reinold
[C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
Zentralblatt für Gynäkologie 1992;114(2):82-5.
1992: Paul Speiser; W Schmid; K Czervenka; M Peschke; Robert Zeillinger; Ernst Kubista
[Frequent point mutations in the p53 tumor suppressor gene in human vulvar cancer].
Gynäkologisch-geburtshilfliche Rundschau 1992;32 Suppl 1():31-2.
1991: Klaus Czerwenka; Robert Zeillinger; fritz kury; Mahmood Manavi; Paul Speiser; M Peschke; U Steinhart; J W Hosmann; Ernst Kubista
[Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Gynäkologische Rundschau 1991;31 Suppl 2():378-9.
1991: Gottfried F Fischer; Winfried F Pickl; Ingrid Faé; V Pausch; Paul Speiser
Elucidation of apparent non-maternity with DNA probes detecting highly polymorphic single locus systems.
Vox sanguinis 1991;60(3):181-3.
1991: Winfried F Pickl; Gottfried F Fischer; I Faè; Paul Speiser
[Identification of an old frozen alcohol blood sample using a genetic probe technique].
Wiener klinische Wochenschrift 1991;103(5):155-7.
1990: Paul Speiser; Gabriele Fischer; Winfried F Pickl; I Fae; V Pausch; M Kribitz
[Usefulness and cogency of gene probes in paternity questions (Personal experiences: 1989/90].
Wiener klinische Wochenschrift 1990;102(22):673-6.
1990: Gabriele Fischer; Paul Speiser
[Assessment of apparent non-maternity using individual specific gene probes].
Wiener klinische Wochenschrift 1990;102(10):309-11.
1990: V Pausch; Paul Speiser; U Michl; Paul Höcker; C P Engelfriet
[Hemolyzing antibodies to markers of the P blood factor system as a problem in blood transfusion and pregnancy. With reference to serology, biochemistry and genetics].
Wiener klinische Wochenschrift 1990;102(3):80-90.
1987: V Pausch; Paul Speiser
[Hemolytic graft versus host reaction cause by immune "auto"-anti A1 formation in an A1 recipient following transplantation of an O kidney. With a review of studies up to now from the literature].
Wiener klinische Wochenschrift 1987;99(15):517-25.
1987: Paul Speiser
[In vitro identification of a child's father via the mother and vice versa by means of the mixed lymphocyte culture test].
Beiträge zu Infusionstherapie und klinische Ernährung 1987;18():357-9.